Valuation: Mecure Industries PLC

Market Cap 225B 167M 149M 137M 124M 233M 15.79B 239M 1.63B 654M 8.36B 627M 614M 26.47B P/E 2024
23.9x
P/E 2025 40.4x
Enterprise Value 274B 203M 181M 166M 151M 284M 19.22B 290M 1.99B 796M 10.17B 763M 747M 32.22B EV / Sales 2024
1.99x
EV / Sales 2025 3.99x
Free-Float
12.71%
Yield 2024
1.08%
Yield 2025 0.49%
6 months-10.65%
Current year-13.80%
1 week 56.2
Extreme 56.2
56.2
1 month 56.2
Extreme 56.2
56.2
Current year 54.55
Extreme 54.55
104
1 year 24.95
Extreme 24.95
104
3 years 5.73
Extreme 5.73
104
5 years 5.73
Extreme 5.73
104
10 years 5.73
Extreme 5.73
104
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+83.06% - 167M
+1.38%+10.92%+57.57%+140.08% 1,255B
+3.21%+1.06%+46.58%+80.55% 641B
+1.91%+1.62%+34.61%+105.81% 505B
+1.25%-0.73%+49.96%+66.94% 381B
+2.78%+5.18%+76.76%+42.06% 357B
+2.10%+3.90%+32.30%+59.38% 303B
+1.92%+9.87%+11.94%+36.47% 286B
+3.83%+5.96%+61.37%+75.48% 249B
+4.32%+9.59%+41.84%+115.01% 208B
Average +2.12%+2.65%+49.60%+80.20% 418.54B
Weighted average by Cap. +2.09%+3.90%+48.56%+93.80%

Financials

2024 2025
Net sales 46.03B 34.2M 30.48M 27.95M 25.4M 47.75M 3.23B 48.84M 334M 134M 1.71B 128M 126M 5.42B 77.69B 57.73M 51.45M 47.18M 42.88M 80.6M 5.46B 82.45M 564M 226M 2.89B 217M 212M 9.15B
Net income 2.33B 1.73M 1.54M 1.41M 1.29M 2.42M 164M 2.47M 16.9M 6.78M 86.56M 6.5M 6.36M 274M 6.46B 4.8M 4.28M 3.92M 3.57M 6.7M 454M 6.86M 46.91M 18.8M 240M 18.03M 17.64M 761M
Net Debt 35.77B 26.58M 23.69M 21.72M 19.74M 37.11M 2.51B 37.96M 260M 104M 1.33B 99.77M 97.64M 4.21B 48.85B 36.3M 32.35M 29.67M 26.96M 50.68M 3.43B 51.84M 355M 142M 1.82B 136M 133M 5.75B
Projected Income Statement - Annual - Mecure Industries PLC
Logo Mecure Industries PLC
Mecure Industries Plc is a human therapeutics company. The Company is principally in the business of manufacturing drugs, such as tablets, capsules and syrups in Nigeria under two categories namely pharmaceuticals and nutraceuticals. The Company’s Pharmaceuticals segment comprises of over 41 drugs, such as Ebu 200 and 400 (ibuprofen tablets), Laclox, Lamox (an amoxicillin formulation) and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consist of approximately 100 products, including multivitamins and dietary supplements. Its products and services include acute ailment medication, chronic ailment medication, nutraceuticals, multivitamins and a planned expansion into chemotherapy medication. It also offers mobile applications, such as the Smart Pill and Smart Buy applications. These applications serve as online pharmacies that facilitate easy purchase and delivery of Company’s products to retail customers in urban cities.
Employees
195
Date Price Change Volume
03/11/26 NGN 56.20 0.00% 88,823
02/11/26 NGN 56.20 0.00% 77,810
30/10/26 NGN 56.20 0.00% 149,430
29/10/26 NGN 56.20 0.00% 323,639
28/10/26 NGN 56.20 0.00% 9,533
  1. Stock Market
  2. Stocks
  3. MECURE Stock